Anti-VMP1 Antibody

(No reviews yet) Write a Review
SKU:
STPA00068
Antibody Type:
Polyclonal
Applications:
WB
Applications:
ICC/IF
Reactivity:
Human
Host Species:
Rabbit
  • Immunocytochemistry/Immunofluorescence analysis using Rabbit Anti-VMP1 Polyclonal Antibody (STPA00068). Tissue: Colon carcinoma cell line (RKO). Species: Human. Fixation: 4% Formaldehyde for 15 min at RT. Primary Antibody: Rabbit Anti-VMP1 Polyclonal Antibody (STPA00068) at 1:100 for 60 min at RT. Secondary Antibody: Goat Anti-Rabbit ATTO 488 at 1:100 for 60 min at RT.
  • Western blot analysis of Human A549 showing detection of 46.2kDa VMP1 protein using Rabbit Anti-VMP1 Polyclonal Antibody (STPA00068). Lane 1: Molecular Weight Ladder (MW). Lane 2: A549 cell lysates. Load: 15 µg. Block: 5% Skim Milk in 1X TBST. Primary Antibody: Rabbit Anti-VMP1 Polyclonal Antibody (STPA00068) at 1:1000 for 16 hours at 4°C. Secondary Antibody: Goat-Anti-Rabbit IgG: HRP at 1:200 for 60 min at RT. Color Development: TMB.
Frequently bought together:

Description

VMP1 Antibody

VMP1 Antibody is a rabbit polyclonal antibody directed against VMP1, offered by Assay Genie for research applications. Reported applications include WB and ICC/IF. Reported reactivity: Human. Purified by Peptide Affinity.

Vacuole Membrane Protein 1 (VMP1) is an endoplasmic reticulum (ER)-localized, multi-spanning membrane protein essential for the initiation of autophagy and the maintenance of ER-organelle communication. VMP1 plays a pivotal role in forming autophagosomes and regulating membrane contact sites between the ER and other organelles, including mitochondria, endosomes, and lipid droplets. In the nervous system, VMP1 is crucial for neuronal homeostasis. It facilitates the clearance of damaged proteins and organelles through the autophagy-lysosome pathway—a process vital for long-lived neurons. Loss of VMP1 function disrupts autophagic flux, leading to the accumulation of protein aggregates, damaged mitochondria, and swollen ER structures. These cellular stressors are strongly associated with the pathogenesis of neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, and amyotrophic lateral sclerosis. Recent studies have shown that VMP1 deficiency in dopaminergic neurons results in progressive motor deficits, axonal degeneration, and α-synuclein accumulation—hallmarks of Parkinsonian neurodegeneration. Mechanistically, VMP1 is required for LC3 recruitment and Beclin-1 interaction, both essential steps in autophagosome formation. As a master regulator of autophagy and ER-organelle dynamics, VMP1 represents a promising therapeutic target for neurodegenerative disease intervention. Its role in maintaining neuronal integrity positions it at the forefront of research into brain aging and neuroprotection. This antibody is also available conjugated to ATTO 390, ATTO 488, ATTO 594, APC, Biotin, FITC, HRP, PerCP and RPE. Supplied in 100 µg. For research use only; not for diagnostic or therapeutic procedures.

View AllClose

0 Reviews

View AllClose